BRAF and melanoma: While patients of cutaneous melanoma harbor mutations in BRAF, RAS, and NF1 related to MAPK activation, few UM patients possess these mutations, but rather mutations in the G-protein α-subunit (Table 1).396 Uveal melanomas display MAP-kinase activation through the GNAQQ209L mutation.